Spire Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
19,128
+8,498
| +80% | +$913K | 0.07% | 220 |
|
|
2025
Q1 | $1.07M | Buy |
10,630
+1,456
| +16% | +$147K | 0.03% | 387 |
|
|
2024
Q4 | $819K | Buy |
9,174
+1,865
| +26% | +$167K | 0.03% | 434 |
|
|
2024
Q3 | $612K | Buy |
7,309
+4,630
| +173% | +$388K | 0.02% | 476 |
|
|
2024
Q2 | $206K | Sell |
2,679
-7
| -0.3% | -$539 | 0.01% | 710 |
|
|
2024
Q1 | $184K | Buy |
2,686
+530
| +25% | +$36.3K | ﹤0.01% | 789 |
|
|
2023
Q4 | $131K | Sell |
2,156
-1,154
| -35% | -$70.3K | ﹤0.01% | 917 |
|
|
2023
Q3 | $175K | Buy |
3,310
+53
| +2% | +$2.8K | 0.01% | 750 |
|
|
2023
Q2 | $176K | Buy |
3,257
+897
| +38% | +$48.5K | 0.01% | 765 |
|
|
2023
Q1 | $118K | Buy |
2,360
+995
| +73% | +$49.8K | ﹤0.01% | 910 |
|
|
2022
Q4 | $63K | Sell |
1,365
-458
| -25% | -$21.1K | ﹤0.01% | 906 |
|
|
2022
Q3 | $71K | Sell |
1,823
-931
| -34% | -$36.3K | ﹤0.01% | 823 |
|
|
2022
Q2 | $103K | Sell |
2,754
-3
| -0.1% | -$112 | ﹤0.01% | 1023 |
|
|
2022
Q1 | $122K | Sell |
2,757
-1,364
| -33% | -$60.4K | ﹤0.01% | 1101 |
|
|
2021
Q4 | $175K | Buy |
4,121
+1,550
| +60% | +$65.8K | ﹤0.01% | 1147 |
|
|
2021
Q3 | $112K | Sell |
2,571
-13,060
| -84% | -$569K | ﹤0.01% | 1151 |
|
|
2021
Q2 | $668K | Sell |
15,631
-2,829
| -15% | -$121K | 0.02% | 531 |
|
|
2021
Q1 | $713K | Buy |
+18,460
| New | +$713K | 0.02% | 554 |
|